Hikma Pharmaceuticals PLC HKMPY:OTCPK

*Data is delayed | Exchange | USD
Last | 03/27/24 EDT
47.48UNCH (UNCH)
Volume
92
52 week range
41.50 - 56.63
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close47.48
  • 52 Week High56.63
  • 52 Week High Date08/14/23
  • 52 Week Low41.50
  • 52 Week Low Date03/31/23

Key Stats

  • Market Cap5,402.91M
  • Shares Out110.94M
  • 10 Day Average Volume328.5
  • Dividend1.44
  • Dividend Yield3.03%
  • Beta0.63
  • YTD % Change4.56

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close47.48
  • 52 Week High56.63
  • 52 Week High Date08/14/23
  • 52 Week Low41.50
  • 52 Week Low Date03/31/23
  • Market Cap5,402.91M
  • Shares Out110.94M
  • 10 Day Average Volume328.5
  • Dividend1.44
  • Dividend Yield3.03%
  • Beta0.63
  • YTD % Change4.56

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/21/2024
  • Div Amount0.94
  • Split Date-
  • Split Factor-

Latest On Hikma Pharmaceuticals PLC

 

Profile

MORE
Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products, supported by its manufacturing facilities in the United States, Europe and Middle...
Said Darwazah
Executive Chairman of the Board
Mazen Darwazah
Executive Vice Chairman of the Board, President of MENA
Riad Mishlawi
Chief Executive Officer, Executive Director
Khalid Nabilsi
Chief Financial Officer
Majda Labadi
Executive Vice President - Organisational Development
Address
1 New Burlington Place
London
W1S 2HR
United Kingdom